Global Electroencephalography Devices Market According to Data Bridge Market Research new Market report, “By Product Type (MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, Electrodes, Sensors, Gels, Cables), By Application (Diagnostics, Therapeutics Segments), By Procedure (Invasive, Non-Invasive), By Disease (TBI, Stroke, Dementia, Epilepsy), By End-Users (Hospitals, Diagnostic Centers, Academics), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2025
This is an electrophysiological monitoring method which is used to record electrical activity of the brain. This is a non-invasive procedure. EEG is most often used to diagnose epilepsy, which causes abnormalities in EEG readings. It is also used to diagnose sleep disorders, depth of anesthesia, coma, encephalopathies, and brain death.
Sleep apnea is also a type of neurological disorder. According to the World Health Organization an estimated of 100 million individuals worldwide have some degree of obstructed sleep apnea (OSA). According to American Sleep Apnea Association report that OSA affects 1 in 4 men and 1 in 9 women in the United States- accounting for an estimated 22 million individuals.
According to the world health organization 35.0% of the deaths in Europe are due to brain disorders. According to the study conducted by Christopher and Dana reeve foundation in the year 2009 it was found that around 5 million peoples in U.S. suffer from some kind of paralysis which is also a type of neurological disorder. And the same study was conducted in the year 2013 and it was found that approximately 1 in 50 people lives with paralysis that is approximately 5.4 million peoples suffering with paralysis across U.S. approximately 1.7% of the total population in U.S reported that they are living with some form of paralysis.
The global market for global electroencephalography devices by the following sub-categories is presented
Increasing prevalence of neurological disorders:
According to National Center for Biotechnology Information, every year about 60,000 Americans are diagnosed with Parkinson’s. An estimated 7 million to 10 million people worldwide have Parkinson’s disease. The prevalence of this disease is 1,900 per 100,000 in those who are above 80 years of age and 41 per 100,000 in fourth decade of life.
As per the Alzheimer's Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. According to Alzheimer disease international, there were an estimated 46.8 million people worldwide living with Alzheimer in 2015 and this number is believed to be close to 50 million people in 2017. And this number is expected to get double every 20 years reaching 75 million in 2030 and 131.5 million by 2050.
Epilepsy is the chronic disorder of the brain which affects almost all ages. According to world health organization, 50 million people worldwide have epilepsy and this number is estimated to increase in coming years which makes it one of the most common neurological disorders.
As the prevalence of the neurological disorders such as Alzheimer's, Epilepsy and Parkinson’s is on the rise, hence this will create a strong platform for this market in future.
Growing geriatric population:
According to the world health organization, between 2015 -2050, the proportion of the global population over 60 years of age will nearly double from 12.0% to 22.0%. By 2050, the world’s population aged 60 years and above is expected to reach 2 billion, up from 900 million in 2015.
As with the growing old age population, this population is supposed to be more exposed to the various neurological disorders, amongst which Alzheimer's is most common.
Some of the major market players in this market are Boston Scientific Corporation, Compumedics Limited, General Electric Company, Medtronic, Natus Medical Incorporated, NIHON KOHDEN CORPORATION, CASMED, Nonin Medical Inc, Tristan Technologies, Inc, Masimo, Cyberonics, Inc., Cochlear Ltd, NeuroPace, Inc, Nevro Corp, Abbot, LivaNova PLC, SECOND SIGHT, SensArs, , CAS Medical Systems, Masimo.
Browse Related Reports:
Europe Brain Monitoring Market By Product Type, End User, Country (Germany, United Kingdom, France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe)–Industry Trends and Forecast to 2024.
Asia-Pacific (APAC) Electroencephalography Devices Market By Product Type, By End-Users, By Distribution Channel, By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Phillipines, Rest of APAC) – Industry Trends and Forecast to 2024.
Europe Electroencephalography Devices Market, By Product Type, By End-Users, By Distribution Channel, By Country (Germany, France, United kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024.
Global Neuroprosthetics Market By Type (Motor Prosthetics , Auditory Prosthetics/Cochlear Implants, Cognitive Prosthetics , Visual Prosthetics/Retinal Implants), By Technology, By Application, By End User( Hospitals, Clinics); Geography (North America, Europe, Asia-Pacific, South America, Middle East, Africa)- Industry Trends and Forecast to 2024.
Europe Electroencephalography Devices Market – Industry Trends and Forecast to 2027
Asia-Pacific Electroencephalography Devices Market – Industry Trends and Forecast to 2027
North America Electroencephalography Devices Market - Industry Trends and Forecast to 2026
Global Electroencephalography Devices Market – Industry Trends - Forecast to 2026